The factor V Leiden mutation may predispose women to severe preeclampsia.
about
Heparin for pregnant women with acquired or inherited thrombophiliasThe placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsiaThrombophilia and pregnancyLow-molecular-weight heparin for the prevention of obstetric complications in women with thrombophiliasProphylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin aloneAmerican College of Medical Genetics consensus statement on factor V Leiden mutation testingGenetic thrombophilias and uterine artery Doppler velocimetry and preeclampsia.Increased resistance to activated protein C and factor V Leiden in recurrent abortions. Review of other hypercoagulability factors.Association between thrombophilia gene polymorphisms and preeclampsia: a meta-analysis.The effect of factor V Leiden carriage on maternal and fetal healthDisentangling fetal and maternal susceptibility for pre-eclampsia: a British multicenter candidate-gene studyThrombophilia in pregnancy.Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are jointly associated with preeclampsia.Evaluation the frequency of factor V Leiden mutation in pregnant women with preeclampsia syndrome in an Iranian population.Cerebrovascular disorders in children with the factor V Leiden mutation.Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations.Preeclampsia from a renal point of view: Insides into disease models, biomarkers and therapy.The phenomenon known as acquired activated protein C resistance.Evaluation of selected thrombotic factors among pregnant women with preeclampsia and normal pregnant women.Applications of polymorphisms and pharmacogenomics in obstetrics and gynecology.How frequent is altered gene expression among susceptibility genes to human complex disorders?Utility of testing for factor V Leiden.Polymorphism in the tumor necrosis factor-alpha gene in women with preeclampsiaRisk factors for umbilical venous catheter-associated thrombosis in very low birth weight infantsGenes and the preeclampsia syndrome.Impact of smoking during pregnancy on functional coagulation testingImmunologic characteristics of preeclampsia, a comprehensive review.Inherited and acquired thrombophilias.Genetic variants in pre-eclampsia: a meta-analysis.Prothrombin 20210 G: a mutation and Factor V Leiden mutation in women with a history of severe preeclampsia and (H)ELLP syndrome.Susceptibility to pre-eclampsia in Finnish women is associated with R485K polymorphism in the factor V gene, not with Leiden mutation.The relationship between thrombophilic mutations and preeclampsia: a prospective case-control study.Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase.Fetal genotype for specific inherited thrombophilias is not associated with severe preeclampsia.Relationship between thrombophilic disorders and type of severe early-onset hypertensive disorder of pregnancy.The C825T polymorphism in the G-protein beta 3 subunit gene in Chinese patients with preeclampsia.Microsatellite marker association at chromosome region 2p13 in Finnish patients with preeclampsia and obstetric cholestasis suggests a common risk locus.Genotype distribution of estrogen receptor alpha polymorphisms in pregnant women from healthy and preeclampsia populations and its relation to blood pressure levels.Maternal carriers of the ANXA5 M2 haplotype are exposed to a greater risk for placenta-mediated pregnancy complications.Thrombophilic mutations in pre-eclampsia and pregnancy-induced hypertension.
P2860
Q24248689-6B9C2935-3A08-4CA5-9D27-42D1DFA86F20Q24795491-A3803DF3-A916-4DF8-9C42-3AEEC890C7F7Q24801115-CCA3AF3F-A29B-4F69-9082-60FFDD5BCBE0Q28193116-47746C7A-4C98-44E9-8C38-72220B03BBCDQ28199764-F20EAE67-D73E-4ABB-B6B2-0F74C5D019A8Q28361651-AA2520D8-9B41-4A09-8CF9-0D270255A623Q30847534-74DE4245-7A64-4E86-92B5-50CDEF48B4DFQ33780732-46BCC72A-B4D1-4266-B54B-0DE231EADE0BQ33812532-728F5042-86EC-488F-8DF7-6CC910FBC99FQ33878487-89D29772-1E21-44BC-9168-2470B1B2B950Q34021020-C5A8D7A4-6F53-45C4-A15A-4BEBD7D95533Q34043661-D7AA84F5-5060-4F53-9B12-165ECEE7C86AQ34143985-D79141B2-54B0-462C-B2BA-F8D8AEE4F539Q34176440-EE5C6CD5-A9C3-4A96-8F19-8818C2E2855FQ34415810-DAD61AE0-4585-4DA2-BADA-79C03623D746Q34450894-E6A73F06-A8FC-4753-A3F1-8E31155FD712Q34453242-471DF324-0C92-4D33-93CD-FF03486F0CD6Q34530144-A8985CED-4E45-4741-9E1C-BF694BDD6E78Q35089745-0A6C54B7-DAD3-46BE-B35A-A45107CB0E7CQ35610515-BF8967BF-4471-43B4-89B4-3403CD24C5C5Q36043405-4861C940-A058-4E21-8B95-5B8BE03F8899Q36159924-BF584238-F1A0-4C5B-A7E5-31B77E7CF6EBQ36308550-3BC11DBD-2E93-47B6-9FAF-902EF2133F31Q36978114-88C70AB8-4A25-4DA5-8B6E-313E4F2BAFC5Q37053831-EA47ECE1-713F-4AEE-BFF6-7F90A3345607Q37163228-E9DE1867-6F35-48A6-8D2D-934493A97F32Q37786350-B68B7EF7-5E52-43A3-9522-48F0B82484C6Q38125276-1D31251F-B539-4CBA-9FAB-CDB1BAC6AB69Q39489329-8921778E-ECA8-41F1-A253-C6C6CA661AA7Q44014222-B7DD7794-6145-459C-8236-D50F374FB486Q44691801-4F81993A-1E05-4395-A743-E43D434C4C50Q45275665-0DB46C3E-EA4E-4E6E-A28C-A13A5326C2E8Q46354712-8CAD3DAE-7733-4F8F-858D-9409AB8058BBQ46398214-060A94ED-6BE2-4144-A863-7237F0B22763Q46860417-8A6157E3-82A9-49BB-B98A-EEAA4C16F53DQ47815461-72D7AE60-4897-4919-B66E-CFB9BE898508Q47996260-2F3E9977-58D4-4812-9B3F-88E05CABBBD0Q51770627-E4ACFF0E-171B-44BB-A672-DEEE657F0A98Q52677785-4A94A9B7-1681-4833-BEAF-6D0FA7385FA3Q54537222-116DC817-4BB9-4B68-8A8B-D68F53CD8443
P2860
The factor V Leiden mutation may predispose women to severe preeclampsia.
description
1996 nî lūn-bûn
@nan
1996 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
The factor V Leiden mutation may predispose women to severe preeclampsia.
@ast
The factor V Leiden mutation may predispose women to severe preeclampsia.
@en
The factor V Leiden mutation may predispose women to severe preeclampsia.
@nl
type
label
The factor V Leiden mutation may predispose women to severe preeclampsia.
@ast
The factor V Leiden mutation may predispose women to severe preeclampsia.
@en
The factor V Leiden mutation may predispose women to severe preeclampsia.
@nl
prefLabel
The factor V Leiden mutation may predispose women to severe preeclampsia.
@ast
The factor V Leiden mutation may predispose women to severe preeclampsia.
@en
The factor V Leiden mutation may predispose women to severe preeclampsia.
@nl
P2093
P1476
The factor V Leiden mutation may predispose women to severe preeclampsia.
@en
P2093
Dizon-Townson DS
P304
P356
10.1016/S0002-9378(96)80022-6
P407
P433
P577
1996-10-01T00:00:00Z